Trials / Conditions / Erosive Gastroesophageal Reflux Disease
Erosive Gastroesophageal Reflux Disease
5 registered clinical trials studyying Erosive Gastroesophageal Reflux Disease — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | JAQBO® Tab. 20 mg(Zastaprazan Citrate) in Erosive GERD NCT07115706 | Jeil Pharmaceutical Co., Ltd. | — |
| Not Yet Recruiting | to Evaluate the Safety/Tolerability and Pharmacokinetics, and Pharmacodynamics of DWP14012 Injection NCT06437951 | Daewoong Pharmaceutical Co. LTD. | Phase 1 |
| Completed | Efficacy and Safety of HIP1601 Capsule NCT04080726 | Hanmi Pharmaceutical Company Limited | Phase 3 |
| Completed | Study to Evaluate the Efficacy and Safety of DWP14012 in Patients With Erosive Gastroesophageal Reflux Disease NCT03184324 | Daewoong Pharmaceutical Co. LTD. | Phase 2 |
| Completed | Efficacy of Pantoprazole in Patients Older Than 12 Years With Reflux Associated Sleep Disorders (PULS) NCT00562094 | Nycomed | — |